Finance
Why Energy Stocks Like ExxonMobil, Phillips 66, and Enterprise Products Partners Fell Today
The good news out of OPEC wasn’t necessarily that good for energy companies.
Why Travel and Entertainment Shares Plunged on Monday
COVID-19 concerns are back again.
Why RingCentral Shares Have Fallen 34% So Far in 2021
The red-hot cloud communications sector is cooling down thanks to widespread vaccination against COVID-19.
Why This Under $10 Silver Stock Rallied 14.8% in the First Half of 2021
Hecla Mining had a lot going for it, and it wasn’t just silver prices.
Is This the Long-Awaited Stock Market Crash?
The Dow was down more than 750 points Monday morning.
Here’s Why Vuzix Shares More Than Doubled in the First Half of 2021
The company’s AR technology is finally starting to reveal its value.
July mARKet Update Webinar
The July mARKet update webinar. This month’s spotlight: ARK’s latest research on the biopharmaceutical pipeline, the online sports betting…
Why Snowflake Stock Fell 14% in the First Half of 2021
Investors weren’t happy with the company’s mounting losses.
Why Shares of Mastercard Are Falling Today
The company appears to be declining along with the broader market amid macroeconomic and pandemic-induced concerns.
Why Square Stock Rose 12% in the First Half of 2021
Investors are concerned about Square’s growing dependency on cryptocurrency revenue.
Here’s What We Look for in Earnings Reports
Earnings season is upon us — here’s your playbook.
Why Shares in General Electric Are Falling Today
Sentiment around the company’s key end market is negative today.
Why Carnival, Norwegian Cruise, and Royal Caribbean Stocks Sank Today
Investors are afraid of the effects of the delta variant.
Why Ford, General Motors, and Churchill Capital IV (Lucid Motors) Stocks Are Down Today
Remember COVID-19? Guess what?
Why NRx Pharmaceuticals Stock Is Skyrocketing Today
The company reported promising data for its experimental COVID-19 drug Zyesami.
Here’s Why Cytokinetics Is Rocketing Higher Today
The company’s new heart drug candidate produced encouraging clinical trial results.
Why Alteryx Stock Plummeted 29% in the First Half of 2021
Disappointing quarterly results and management issues plagued the company earlier this year.
Why Cameco Stock Rocketed 43% in the First Half of 2021
Investors are betting on stronger uranium markets.